Lead Poisoning presenting as acute severe myalgia: Why was the diagnosis delayed and what lessons can we learn as acute physicians?

Lead Poisoning presenting as acute severe myalgia: Why was the diagnosis delayed and what lessons can we learn as acute physicians?

Abstract

Patients presenting to the “front door” with acute neuromuscular symptoms are challenging. Toxins need consideration as possible causative agents if there is the possibility of relevant exposure. This requires a thorough history1 and an awareness of local ethnic, social and industrial cultures within the practice locality. We describe a case of lead poisoning in a 35 year old man who presented with severe, progressive, myalgia. We consider that basic errors in clinical processing delayed a potentially difficult and serious diagnosis and these are discussed. The importance of maintaining a thorough initial clerking process within the Acute Medical Unit is highlighted. This should include a comprehensive occupational history. Acute physicians should familiarize themselves with local industry and the toxic syndromes they can produce.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

  1. Goldman RH, Peters JM. The Occupational and Environmental Health History. JAMA 1981; 246(24): 2831–6.
  2. Pearce JMS. Burton’s Line in Lead poisoning. Eur Neurol 2007; 57: 118–119.
  3. Roscoe RJ, Ball W, Curran JJ et al. Adult blood lead epidemiology and surveillance United States. Morbidity & Mortality Weekly Report. Surveillance Summaries, 2002; 51(11):1–10.
  4. Bordage G. Why did I miss the diagnosis? Some cognitive explanations and educational implications. Acad Med 1999; 74: 138–142.
  5. Brooks LR, Norman GR, Allen SW. Role of specific similarity in a medical diagnostic task. J Exp Psychol Gen 1991; 120: 278–287.
  6. Schmidt HG, Norman GR, Boshuizen HPA. A cognitive perspective on medical expertise: theory and implications. Acad Med 1990; 65: 611–621.
  7. Elstein AS, Schwartz A. Clinical problem solving and diagnostic decision making: selective review of the cognitive literature. BMJ 2002; 324(7339): 729–32.
  8. Agency for Toxic substances and Disease registry, US Department of Health and Human Services. Toxicological Profile for Lead, 2007
  9. Lead, www.toxbase.org, National Poisons Information Service, 2008.
  10. Needleman H. Low Level Lead Exposure: history and discovery. Annals of Epidemiology 2009 Apr; 19(4): 235–8.
  11. Rabinowitz MB. Toxicokinetics of bone lead. Environ Health Perspect 1991 Feb; 91: 33–7.
  12. Hu H. Bone lead as a new biological marker of lead dose. Recent findings and implications for public health. Environ Health Perspect 1998 Aug: 106 (4): 961–7.
  13. Hu H, Shih R, Rothenburg S, Schwartz BS. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodological issues. Environ Health Perspect 2007 Mar; 115(3): 455–62.
  14. Grandjean P, Jacobsen IA, Jorgensen PJ. Chronic lead poisoning treated with dimercaptosuccinic acid. Pharmacol Toxicol 1991 Apr: 68(4): 266–9.
  15. Fischbein, A, Hu, H. Occupational and environmental exposure to lead. In: Environmental and Occupational Medicine, Rom, WN and Markowitz, SB (Eds), Philadelphia, Wolters Kluwer/Lippincott Williams & Wilkins 2007. p. 958.
  16. Thomson RM, Parry GJ. Neuropathies associated with excessive exposure to lead. Muscle Nerve 2006 Jun; 33(6): 732–41.
  17. Shih Ra, Glass TA, Bandeen-Roche K et al. Environmental lead exposure and cognitive function in community-dwelling older adults. Neurology 2006 Nov; 67(9): 1556–62.
  18. Lancranjan I, Popescu HI, Gavanescu O et al. Reproductive ability of workmen occupationally exposed to lead. Arch Environ Health 1975 Aug; 30(8): 396–401.
  19. Inglis JA, Henderson DA, Emmerson BT. The pathology and pathogenesis of chronic lead nephropathy occurring in queensland. J Pathol 1978 Feb; 124(2): 65–76.

Request Permissions

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center’s (CCC) Marketplace website by clicking the button below:

Get Permission

Lead Poisoning presenting as acute severe myalgia: Why was the diagnosis delayed and what lessons can we learn as acute physicians?

3rd March 2016
PMID: 21597564
Authors Affiliations
JM McLaren (MBChB, MRCP UK) Department of Medicine, Hutt Valley Hospital, Lower Hutt, New Zealand
T Petterson (MBChB, Bsc Hons, MD, FRCP) Department of Medicine, Hutt Valley District Health Board, Hutt Hospital, High Street, Lower Hutt, Private Bag 31-907 Lower Hutt, 5040 New Zealand; Tel.: +64 (0)4 566 6999 Email: timothy.petterson@ huttvalleydhb.org.nz
DCR McGouran (MBChB) Department of Medicine, Hutt Valley Hospital, Lower Hutt, New Zealand

Lead Poisoning presenting as acute severe myalgia: Why was the diagnosis delayed and what lessons can we learn as acute physicians?

Cite this article as:

Petterson T, McLaren J, McGouran D. Lead Poisoning presenting as acute severe myalgia: Why was the diagnosis delayed and what lessons can we learn as acute physicians? Acute Med. 2010;9(1):24-6. PMID: 21597564.

Lead Poisoning presenting as acute severe myalgia: Why was the diagnosis delayed and what lessons can we learn as acute physicians?

Share this article

Click the icon of the social media platform on which you would like to share this article.


Shopping Basket
Scroll to Top